3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Polycystic Ovary Syndrome
1
Oligodendroglioma
1
Neoplasms
1
Glucose Metabolism Disorders
1
Glucose Intolerance
1
Glioblastoma
1
Fatty Liver
1
Astrocytoma
1
Interventions
Temozolomide
61
Radiotherapy
25
Bevacizumab
21
Magnetic Resonance Spectroscopy
20
Irinotecan
18
Filgrastim
15
Carboplatin
15
Carmustine
11
Surgical Procedures, Operative
10
Etoposide
9
antineoplaston AS 2-1
8
antineoplaston A10
8
Specimen Handling
8
sargramostim
7
Radiation
7
Peripheral Blood Stem Cell Transplantation
7
Everolimus
7
Biopsy
7
Vincristine
6
Radiotherapy, Intensity-Modulated
6
Procarbazine
6
O(6)-benzylguanine
6
Erlotinib Hydrochloride
6
Topotecan
5
Melphalan
5
Magnetic Resonance Imaging
5
Lomustine
5
Genetic Therapy
5
Cyclophosphamide
5
Aminolevulinic Acid
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Astrocytoma
×
Proton Magnetic Resonance Spectroscopy
×
Clear all
NCT00645385
2019-06-04
Gliadel-MRS
Weill Medical College of Cornell University
Withdrawn